Related Experiment Video
Updated: Mar 14, 2026

Conducting Multiple Imaging Modes with One Fluorescence Microscope
Published on: October 28, 2018
Microdose fluorescence imaging of ABY-029 on an operating microscope adapted by custom illumination and imaging
Jonathan T Elliott1, Alisha V Dsouza1, Kayla Marra1
1Center for Imaging Medicine, Thayer School of Engineering, Dartmouth College, 1 Medical Center Drive, Lebanon, NH 03756, USA.
Abstract:
Fluorescence guided surgery has the potential to positively impact surgical oncology; current operating microscopes and stand-alone imaging systems are too insensitive or too cumbersome to maximally take advantage of new tumor-specific agents developed through the microdose pathway. To this end, a custom-built illumination and imaging module enabling picomolar-sensitive near-infrared fluorescence imaging on a commercial operating microscope is described. The limits of detection and system specifications are characterized, and in vivo efficacy of the system in detecting ABY-029 is evaluated in a rat orthotopic glioma model following microdose injections, showing the suitability of the device for microdose phase 0 clinical trials.
Insights
A new near-infrared fluorescence imaging system enhances surgical oncology by enabling picomolar sensitivity for tumor-specific agents. This custom device is suitable for microdose phase 0 clinical trials, improving tumor detection during surgery.
Area of Science:
- Surgical Oncology
- Medical Imaging
- Biotechnology
Background:
- Fluorescence-guided surgery shows promise in oncology but is limited by current imaging technology.
- Existing systems lack the sensitivity or portability needed for novel tumor-specific agents.
- The microdose pathway offers new agents but requires advanced detection methods.
Purpose of the Study:
- To develop a highly sensitive near-infrared fluorescence imaging system for surgical oncology.
- To evaluate the system's performance with tumor-specific agents in preclinical models.
- To assess the device's suitability for microdose (Phase 0) clinical trials.
Main Methods:
- A custom illumination and imaging module was integrated with a commercial operating microscope.
- The system's limits of detection and specifications were rigorously characterized.
- In vivo efficacy was tested in a rat orthotopic glioma model using ABY-029 after microdose administration.
Main Results:
- The developed system achieves picomolar sensitivity for near-infrared fluorescence imaging.
- System specifications were defined, demonstrating its advanced capabilities.
- The device successfully detected ABY-029 in a rat glioma model, validating its in vivo performance.
Conclusions:
- The custom-built fluorescence imaging module significantly enhances surgical oncology capabilities.
- The system's high sensitivity and portability make it ideal for utilizing microdose agents.
- This technology is well-suited for microdose Phase 0 clinical trials, advancing precision surgery.
Related Concept Videos
Super-resolution Fluorescence Microscopy
Imaging Biological Samples with Optical Microscopy
In optical microscopy, the specimen to be viewed is placed on a glass slide and clipped on the stage...
Confocal Fluorescence Microscopy
Immunofluorescence Microscopy

